000 01629 a2200469 4500
005 20250515012407.0
264 0 _c20060831
008 200608s 0 0 eng d
022 _a0969-7128
024 7 _a10.1038/sj.gt.3302706
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBiglari, A
245 0 0 _aHuman monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo.
_h[electronic resource]
260 _bGene therapy
_cApr 2006
300 _a602-10 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCarcinoembryonic Antigen
_ximmunology
650 0 4 _aCell Line, Tumor
650 0 4 _aCells, Cultured
650 0 4 _aCytokines
_ximmunology
650 0 4 _aGenetic Engineering
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aGreen Fluorescent Proteins
_xgenetics
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aMonocytes
_ximmunology
650 0 4 _aNeoplasm Transplantation
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aReceptors, IgG
_ximmunology
650 0 4 _aRecombinant Proteins
_xmetabolism
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTransplantation, Heterologous
700 1 _aSouthgate, T D
700 1 _aFairbairn, L J
700 1 _aGilham, D E
773 0 _tGene therapy
_gvol. 13
_gno. 7
_gp. 602-10
856 4 0 _uhttps://doi.org/10.1038/sj.gt.3302706
_zAvailable from publisher's website
999 _c16015037
_d16015037